- Visibility 389 Views
- Downloads 652 Downloads
- Permissions
- DOI 10.18231/j.ijcaap.2025.014
-
CrossMark
Study of hemp tribe HEMPOWHER granules on DHEA- induced PCOS in Sprague Dawley (SD) rat model
- Author Details:
-
Leela Priyanka G C
-
Balasekar Premkumar *
-
Arumugam Meena
-
Arumugam Shanthy
-
Manepalli Nageswara Rao Gupta
-
Gopalakrishnan Saravanan
-
Sallabuthula Rajkumar
Leela Priyanka G C
Balasekar Premkumar *
Background: Polycystic ovary syndrome (PCOS) is the common hormonal condition that affects adult women of reproductive age. PCOS can cause hormonal imbalance, excess androgen levels, and cysts in the ovary; irregular periods with a lack of ovulation can make it difficult to become pregnant. Lifestyle changes can improve PCOS symptoms, but medications and fertility treatments are not effective. The goal of this study is to see how Hemp Tribe HempowHer effects PCOS caused by Dehydroepiandrosterone (DHEA) in rats, and to compare it with the standard drug metformin hydrochloride.
Materials and Methods: DHEA was injected into a group of female rats to induce PCOS. Twenty-one days after induction of PCOS, Hem Tribe HempowHer granules and Metformin Hydrochloride were administered to the PCOS-induced animals orally for 14 days. Their body weight, hormone levels, estrous cycles, and histopathological studies were conducted and compared with the normal, standard metformin hydrochloride-administered animals.
Results: The results indicated body weight reduction in both the metformin hydrochloride-treated group and the HempowHer-treated group. Vaginal smear after 21 days of PCOS induction and 14 days after treatment with HempowHer showed normalization of the estrous cycle when compared to PCOS-induced groups. Hormonal analysis 21 days after induction of PCOS followed by 14 days of treatment with HempowHer significantly regulated the hormonal levels of luteinizing hormone, testosterone, progesterone, prolactin, and insulin when compared to the PCOS-induced group. Significant reduction of atretic follicles and increase in corpus luteum shown in histopathological studies of HempowHer-treated animals when compared to the PCOS-induced group indicate that the HempowHer supplement increases the possibility of the regulation of the estrous cycle, reduces the formation of ovary cysts, and improves ovary health.
Conclusion: The HempowHer, as per the study, regulates the estrous cycle and hormonal levels pertaining to ovary health and reproduction, reduces cyst formation, and ameliorates symptoms of PCOS.
Keywords: Cannabinoids, Women's health, Fertility, Ovary, Preclinical, Androgen.
References
- Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis, and diagnosis. Nat Rev Endocrinol. 2011;7(4):219–31.
- Zangeneh FZ, Jafarabadi M, Naghizadeh MM, Abedinia N, Haghollahi F. Psychological distress in women with polycystic ovary syndrome from Imam Khomeini Hospital, Tehran. J Reprod Infertil. 2012;13(2):111–5.
- Ahmad I, Shagufta. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer. Eur J Med Chem. 2015;102:375–
- Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030.
- Wang D, Wang W, Liang Q, He X, Xia Y, Shen S, et al. DHEA- induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway. J Ovarian Res. 2018;11(1):6.
- Kaushik S, Satapathy T, Roy A, Gupta PP, Purabiya P. Endocannabinoid activation and polycystic ovary syndrome: A systematic review. Res J Pharm Tech. 2020;13(1):448–52.
- Ab Hamid N, Abu Bakar AB, Mat Zain AA, Nik Hussain NH, Othman ZA, Zakaria Z, et al. Composition of Royal Jelly (RJ) and its anti-androgenic effect on reproductive parameters in a polycystic ovarian syndrome (PCOS) animal model. Antioxidants. 2020;9(6):499.
- Osuka S, Nakanishi N, Murase T, Nakamura T, Goto M, Iwase A, et al. Animal models of polycystic ovary syndrome: A review of hormone-induced rodent models focused on the hypothalamus- pituitary-ovary axis and neuropeptides. Reprod Med Biol. 2018;18(2):151–60.
- Iwasa T, Matsuzaki T, Tungalagsuvd A, Munkhzaya M, Yiliyasi M, Kato T, et al. Effects of chronic DHEA treatment on central and peripheral reproductive parameters, the onset of vaginal opening and the estrous cycle in female rats. Gynecol Endocrinol. 2016;32(9):752–5.
- Imani B, Eijkemans MJ, de Jong FH, Payne NN, Bouchard P, Giudice LC, et al. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in infertility. J Clin Endocrinol Metab. 2000;85(2):676–82.
- Raja MA, Maldonado M, Chen J, Zhong Y, Gu J. Development and evaluation of curcumin-encapsulated self-assembled nanoparticles as potential remedial treatment for pCOS in a female rat model. Int J Nanomedicine. 2021;16:6231–47.
- Gu Y, Zhou G, Zhou F, Li Y, Wu Q, He H, et al. Gut and Vaginal Microbiomes in PCOS: Implications for Women's Health. Front Endocrinol (Lausanne). 2022;13:808508
- Joshi A. PCOS stratification for precision diagnostics and treatment. Front Cell Dev Biol. 2024;12:1358755.
- Szczuko M, Kikut J, Szczuko U, Szydłowska I, Nawrocka- Rutkowska J, Ziętek M, et al. Nutrition strategy and lifestyle in polycystic ovary syndrome—narrative review. Nutrients. 2021;13(7):2452.
- Han Y, Wu H, Sun S, Zhao R, Deng Y, Zeng S, Chen J. Effect of high-fat diet on disease development of polycystic ovary syndrome and lifestyle intervention strategies. Nutrients. 2023;15(9):2230.
- Coşar A, Özcan P, Tanoglu FB, Tok OE, Özkara G, Timur HT, et al. Comparative effects of the antioxidant glutathione with metformin and Diane-35 on hormonal, metabolic, and inflammatory indicators in a DHEA-induced PCOS rat model. Gynecol Endocrinol. 2024;40(1):2302086.
- Han Q, Wang J, Li W, Chen ZJ, Du Y. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome. Microbiome. 2021;9(1):101.
- Armanini D, Boscaro M, Bordin L, Sabbadin C. Controversies in the pathogenesis, diagnosis, and treatment of PCOS: Focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. 2022;23(8):4110.
- Zhang KH, Zhang FF, Zhang ZL, Fang KF, Sun WX, Kong N, et al. Follicle-stimulating hormone controls granulosa cell glutamine synthesis to regulate ovulation. Protein Cell. 2024;15(7):512–29
- Greff D, Juhász AE, Váncsa S, Váradi A, Sipos Z, Szinte J, et al. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2023;21(1):10.
- Malini NA, Roy GK. Influence of Insulin on LH, Testosterone, and SHBG in Various PCOS Categories Based on the Mode of Secretion of LH in Relation to FSH Levels. Acta Endocrinol (Buchar). 2021;17(3):313–18.
- MacLean JA 2nd, Hayashi K. Progesterone Actions and Resistance in Gynecological Disorders. Cells. 2022;11(4):647
- Naseri L, Khazaei MR, Khazaei M. Potential Therapeutic effect of bee pollen and metformin combination on testosterone and estradiol levels, apoptotic markers, and total antioxidant capacity in a rat model of polycystic ovary syndrome. Int J Fertil Steril. 2021;15(2):101–7.
- He Y, Li X, Li Y, Kuai D, Zhang H, Wang Y, et al. Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in a rat model. Steroids. 2024;206:109424.
- Zhao F, Cui W, Fang C, Luo Y, Zhang C. Chiglitazar ameliorates dehydroepiandrosterone-induced polycystic ovary syndrome in rats. J Ovarian Res. 2024;17(1):229.
- Wang Z, Nie K, Su H, Tang Y, Wang H, Xu X, et al. Berberine improves ovulation and endometrial receptivity in polycystic ovary syndrome. Phytomedicine. 2021;91:153654.
- Yong Z, Mimi C, Yingjie L, Yichen G, Yansu Y, Zhi Z, et al. Mangiferin ameliorates polycystic ovary syndrome in rats by modulating insulin resistance, gut microbiota, and ovarian cell apoptosis. Front Pharmacol. 2024;15:1457467.
- Zia T, Liaqat I, Shahzad KA, Lashari MH, Fouad D, Ataya FS, et al. Ameliorative effect of Fagonia indica-coated chitosan nanoparticles on the ovulatory pattern in a PCOS rat model. J Ovarian Res. 2025;18(1):44. Priyanka G C et al. / IP International Journal of Comprehensive and Advanced Pharmacology 2025;10(2):94–103 103
- Vakili S, Koohpeyma F, Samare-Najaf M, Jahromi BN, Jafarinia M, Samareh A, et al. The effects of l-tartaric acid on ovarian histostereological and serum hormonal analysis in an animal model of polycystic ovary syndrome. Reprod Sci. 2024; 31(11):3583–94.
- Sharafieh G, Salmanifarzaneh F, Gharbi N, Sarvestani FM, Rahmanzad F, Razlighi MR, et al. Histological and molecular evaluation of Mentha arvensis extract on a polycystic ovary syndrome rat model. JBRA Assist Reprod. 2023; 27(2):247–53.
- Fang YQ, Ding H, Li T, Zhao XJ, Luo D, Liu Y, Li Y. N- acetylcysteine supplementation improves endocrine-metabolism profiles and ovulation induction efficacy in polycystic ovary syndrome. J Ovarian Res. 2024;17(1):205.
- Noroozzadeh M, Behboudi-Gandevani S, Zadeh-Vakili A, Ramezani Tehrani F. Hormone-induced rat model of polycystic ovary syndrome: A systematic review. Life Sci. 2017;191:259–72.
- Kumar GS, Tirgar P, Dalal M. Development and evaluation of novel rodent model of PCOS mimicking clinical phenotype in human disease. Middle East Fertil Soc J. 2022;27(1):25.